Net income -- $51 million, achieving a record and representing more than 16% year-over-year growth. GAAP EPS -- $0.34 per ...

I reiterate my buy rating on assets tracking main American indices, supported by strong earnings and favorable momentum.

Erasca is a high-risk, high-reward clinical-stage biotech focused on RAS/MAPK pathway-driven cancers. Click here to read this ...

A10 continued to deliver growth and profitability in the second quarter. This performance demonstrates the continued ...

GAAP NIM increased to 2.64%, and core NIM to 2.62%, both expanding 10 basis points sequentially. Noninterest-bearing deposits ...

If you have ever asked what is Crypto Heatmap analysis, the short answer is that it is a visual way to read blockchain and ...